Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

BD to purchase pharmacy automation firm Parata Systems

By Brian Buntz | June 6, 2022

BD and Parata Systems logosBD (Becton, Dickinson and Company) (NYSE:BDX) has partnered with the private equity firm Frazier Healthcare Partners to acquire Parata Systems, a provider of pharmacy automation solutions. The purchase price of the acquisition is $1.525 billion.

Founded in 2006, Parata Systems offers a range of products and services, including medication adherence packaging technology and perpetual inventory management.

The Durham, North Carolina–based company has positioned its automation technology and software as a means to enable pharmacists to focus more on clinical work and patient interactions.

BD (Franklin Lakes, New Jersey) says the acquisition of Parata will complement its existing medication management portfolio. In particular, Parata will give its new parent access to the $600 million pharmacy automation market segment.

“Parata expands BD’s solutions to a new area of the high-growth pharmacy automation space and is a prime example of BD executing our disciplined M&A strategy,” said Tom Polen, BD CEO, in a statement. “Parata has a highly attractive financial profile and compelling value proposition that meets all of our rigorous investment criteria on growth, profitability and returns. With the addition of Parata, BD further advances our 2025 growth strategy around smart, connected care and enabling new care settings. We look forward to welcoming the talented Parata team to BD.”

“BD is a great home for our company, innovative solutions and technology, and Parata’s team members,” said Rob Kill, CEO of Parata Systems, in a news release.

BD expects the transaction to close by March 31, 2023, the close of the first half of its fiscal year.

The transaction is subject to customary closing conditions.

Parata generated $220 million in the 12-month period ending on March 31, 2022.

BDX shares ticked up 2.13% to $257.65 in late-morning trading.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Wyzo
Wyzo high-speed pick-and-place sidebot wins design awards
Cambridge Pharma launches with UK plant in Cambridge Research Park
Millipore Sigma
MilliporeSigma introduces excipient with sugar-like flavor
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards